Related Experiment Videos
[The CUP syndrome--malignant disease with unknown primary tumor. Part 4: Therapy and prognosis]
1Medizinische Klinik II, Universität Marburg/Lahn.
Fortschritte Der Medizin
|November 10, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study.
Alimentary pharmacology & therapeutics·2011
[Spleen ruptures after screening colonoscopy].
Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2010
Clinical course of laryngo-respiratory symptoms in gastro-oesophageal reflux disease during routine care--a 5-year follow-up.
Alimentary pharmacology & therapeutics·2009
Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD study.
Alimentary pharmacology & therapeutics·2009
Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study.
Alimentary pharmacology & therapeutics·2008
Long-term treatment of patients with gastro-oesophageal reflux disease in routine care - results from the ProGERD study.
Alimentary pharmacology & therapeutics·2007
[Interventional therapy of BPH syndrome].
Fortschritte der Medizin·1999
[Practical conducting of blood pressure measuring. Important contributing factors and possibilities of errors].
Fortschritte der Medizin·1999
Comparative outcomes of advanced medical rescue therapies in steroid-refractory acute severe ulcerative colitis: a systematic review and network meta-analysis.
Frontiers in gastroenterology (Lausanne, Switzerland)·2026
Early multimodal vasopressor strategy in septic shock: results of the TRICYCLE randomized controlled trial.
Critical care (London, England)·2026
Long-term outcomes of prophylactic cardioprotection in early-stage breast cancer patients on non-anthracycline anti-HER2 therapy.
Cardio-oncology (London, England)·2026
Continuous infusion of granulocyte colony-stimulating factor is associated with an advantage in neutrophil recovery in pediatric oncologic disorders.
Cancer chemotherapy and pharmacology·2026
Ciprofloxacin beyond antibacterial therapy: pharmacological mechanisms, anticancer activity, and translational limitations.
Naunyn-Schmiedeberg's archives of pharmacology·2026